Showing results (611-620 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cellsT K Hoffmann, N Meidenbauer, J Müller-Berghaus, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processingB Tirosh, M Fridkin, E Tzehoval, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Tumor vaccination that enhances antitumor T-cell responses does not inhibit the growth of established tumors even in combination with interleukin-12 treatment: the importance of inducing intratumoral T-cell migrationP Gao, Y Uekusa, C Nakajima, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Antitumor activity of interleukin-18 on mouse glioma cellsT Kikuchi, Y Akasaki, T Joki, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Semiallogeneic cell hybrids as therapeutic vaccines for cancerD A Newton, C Romano, S Gattoni-CelliJournal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
Immunoadsorption in multifocal motor neuropathyJ Finsterer, K DerflerJournal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinomaWalter Reinisch, Margareta Holub, Andreas Katz, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomasP A Fetsch, J Cormier, Y M HijaziJournal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patientsG D MacLean, M A Reddish, B M LongeneckerJournal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 studyS P Reddy, R M Harwood, D F Moore, et al.Pageof 176